Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibiotics for cancer treatment: A double-edged sword
Yuan Gao, Qingyao Shang, Wenyu Li, et al.
Journal of Cancer (2020) Vol. 11, Iss. 17, pp. 5135-5149
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Mitochondrial RNA modifications shape metabolic plasticity in metastasis
Sylvain Delaunay, Gloria Pascual, Bohai Feng, et al.
Nature (2022) Vol. 607, Iss. 7919, pp. 593-603
Open Access | Times Cited: 198
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
Antibiotics: Conventional Therapy and Natural Compounds with Antibacterial Activity—A Pharmaco-Toxicological Screening
Daniel Florin Pancu, Alexandra-Denisa Semenescu, Ioana Macașoi, et al.
Antibiotics (2021) Vol. 10, Iss. 4, pp. 401-401
Open Access | Times Cited: 139
Bacterial Infections and Cancer: Exploring This Association And Its Implications for Cancer Patients
Kafayat Yusuf, Venkatesh Sampath, Shahid Umar
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3110-3110
Open Access | Times Cited: 55
Chitosan-Based Nanoparticles with Optimized Parameters for Targeted Delivery of a Specific Anticancer Drug—A Comprehensive Review
Joanna Kurczewska
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 503-503
Open Access | Times Cited: 42
Microbiome as a biomarker and therapeutic target in pancreatic cancer
Ghazaleh Pourali, Danial Kazemi, Amir Shayan Chadeganipour, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 22
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Microbes Saving Lives and Reducing Suffering
Kenneth N. Timmis, Zeynep Ceren Karahan, Juan L. Ramos, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges
Jonaid Ahmad Malik, Sakeel Ahmed, Bisma Jan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112375-112375
Open Access | Times Cited: 76
Enhancing autophagy in Alzheimer's disease through drug repositioning
Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108171-108171
Closed Access | Times Cited: 69
Gut microbiota-mediated immunomodulation in tumor
Xinyi Liu, Yanjie Chen, Si Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 68
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 51
The Challenge of Overcoming Antibiotic Resistance in Carbapenem-Resistant Gram-Negative Bacteria: “Attack on Titan”
Giuseppe Mancuso, Silvia De Gaetano, Angelina Midiri, et al.
Microorganisms (2023) Vol. 11, Iss. 8, pp. 1912-1912
Open Access | Times Cited: 41
Ursolic acid: a natural modulator of signaling networks in different cancers
Sameen Zafar, Khushbukhat Khan, Amna Hafeez, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 39
Screening for Coronary Artery Disease in Cancer Survivors
R. Velusamy, Mark Nolan, Andrew Murphy, et al.
JACC CardioOncology (2023) Vol. 5, Iss. 1, pp. 22-38
Open Access | Times Cited: 39
The Promising Potential of Reverse Vaccinology-Based Next-Generation Vaccine Development over Conventional Vaccines against Antibiotic-Resistant Bacteria
Kanwal Khalid, Chit Laa Poh
Vaccines (2023) Vol. 11, Iss. 7, pp. 1264-1264
Open Access | Times Cited: 34
Structure-activity of chlormethine fluorescent prodrugs: Witnessing the development of trackable drug delivery
Wenfang Jin, Baolei Fan, Xinrui Qin, et al.
Coordination Chemistry Reviews (2023) Vol. 480, pp. 214999-214999
Open Access | Times Cited: 26
Mitochondria Deregulations in Cancer Offer Several Potential Targets of Therapeutic Interventions
Clara Musicco, Anna Signorile, Vito Pesce, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10420-10420
Open Access | Times Cited: 25
Cell membrane-coated nanoparticles for targeting carcinogenic bacteria
Lei Sun, Dan Wang, Kailin Feng, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115320-115320
Closed Access | Times Cited: 9
The Role of Gut Microbiota in Modulating Cancer Therapy Efficacy
Mostafa A. Madkour, Rawan A. Altaf, Zeinab S. Sayed, et al.
Advanced Gut & Microbiome Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 9
Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy
Wenyu Li, Xiaorong Deng, Tingtao Chen
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 45
Advantages of combined photodynamic therapy in the treatment of oncological diseases
Mikhail A. Grin, Nikita Suvorov, Petr Ostroverkhov, et al.
Biophysical Reviews (2022) Vol. 14, Iss. 4, pp. 941-963
Open Access | Times Cited: 31
Nisin ZP, an Antimicrobial Peptide, Induces Cell Death and Inhibits Non-Small Cell Lung Cancer (NSCLC) Progression in vitro in 2D and 3D Cell Culture
Suyash M. Patil, Nitesh K. Kunda
Pharmaceutical Research (2022) Vol. 39, Iss. 11, pp. 2859-2870
Closed Access | Times Cited: 29
The Use of Medicinal Plant-Derived Metallic Nanoparticles in Theranostics
Jabulile Happiness Xulu, Tanaka Ndongwe, Kenneth Maduabuchi Ezealisiji, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2437-2437
Open Access | Times Cited: 28
The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone
Zeyang Shao, Heng Wang, Haiyan Ren, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5678-5678
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top